Ondansetron Injection bulk supplier for pharma manufacturers

Ondansetron Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL

Reference Brands: Zofran(US & EU)

Ondansetron Injection (2 mg/2 mL, 4 mg/2 mL, 8 mg/4 mL) is used in oncology to prevent chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). Available in both U.S. and EU, this 5-HT3 receptor antagonist is administered via IV injection. Ondansetron effectively blocks serotonin to reduce nausea and vomiting, improving patient comfort during cancer treatments. It's a key product in oncology B2B distribution, ensuring better quality of care for patients undergoing chemotherapy and radiation therapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Ondansetron Injection 2 mg/2 mL, 4 mg/2 mL, and 8 mg/4 mL is an essential medication in oncology for the prevention of chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). As a 5-HT3 receptor antagonist, it effectively blocks serotonin, reducing nausea and vomiting associated with highly emetogenic chemotherapy. Ondansetron is available in IV solution form and is widely used in oncology B2B distribution across the U.S. and EU. It plays a vital role in improving patient comfort during cancer treatment.

Ondansetron Injection — third party manufacturing & bulk supply

Ondansetron Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ondansetron Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ondansetron Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ondansetron Injection →

Back to Listing

Frequently Asked Questions

Ondansetron Injection is listed as Injection in 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ondansetron Injection is referenced against Zofran(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.